F. Hoffmann-La Roche Ltd: Roche has rapidly developed additi

Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutionsThree

Related Keywords

United States , America , Nathalie Meetz , Karl Mahler , Sabine Borngr , Gerard Tobin , Bruno Eschli , Birgit Masjost , Sileia Urech , Loren Kalm , Karsten Kleine , Drug Administration , Roche Group Media Relations , Hoffmann , Oche , Apidly , Eveloped , Dditional , Testing , Options , Differentiate , Mutations , Micron , Cars , Variant ,